Your browser doesn't support javascript.
loading
Clinical benefit of depth of response for relapsed/refractory multiple myeloma patients treated on clinical trials: retrospective analysis from two tertiary centres.
Chan, Esther H L; De-Silva, Dunnya; Lin, Adeline H F; Rabin, Neil; Wechalekar, Ashutosh; Popat, Rakesh; Chng, Wee Joo; Yong, Kwee L.
Afiliação
  • Chan EHL; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore.
  • De-Silva D; Cancer Institute, University College London, London, UK.
  • Lin AHF; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore.
  • Rabin N; Department of Haematology, University College London Hospital, London, UK.
  • Wechalekar A; Department of Haematology, University College London Hospital, London, UK.
  • Popat R; Cancer Institute, University College London, London, UK.
  • Chng WJ; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore.
  • Yong KL; Cancer Institute, University College London, London, UK.
Br J Haematol ; 186(1): 162-165, 2019 07.
Article em En | MEDLINE | ID: mdl-30592025
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article